Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: A nationwide follow-up study from Sweden

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Zöller, Bengt ^a   Li, Xinjun ^a   Sundquist, Jan ^a,b   Sundquist, Kristina ^a  

^a LUND UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDISON DISEASE; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; CROHN DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAVES DISEASE; HASHIMOTO DISEASE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POLYMYOSITIS; PSORIASIS; RHEUMATIC FEVER; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; STANDARDIZED INCIDENCE RATIO; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; IMMUNE SYSTEM DISEASES; INCIDENCE; MALE; RISK ASSESSMENT; SEX DISTRIBUTION; STROKE; SWEDEN; YOUNG ADULT;

EID: 84862241966     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-41     Document Type: Article

References (35)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008, 371:1612-23. 10.1016/S0140-6736(08)60694-7, 18468545.
2. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-74.
3. van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ES, Tak PP. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008, 47:3-7. 10.1093/rheumatology/kem202, 17702769.
4. Hansson GK, Hermansson A. T. The immune system in atherosclerosis. Nature Immunology 2011, 12:204-212.
5. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005, 112:3337-47. 10.1161/CIRCULATIONAHA.104.507996, 16301360.
6. López-Pedrera C, Pérez-Sánchez C, Ramos-Casals M, Santos-Gonzalez M, Rodriguez-Ariza A, José Cuadrado M. Cardiovascular risk in systemic autoimmune diseases 2012, epigenetic mechanisms of immune regulatory functions, Clin Dev Immunol, In press.
7. Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010, 30(5-6):8-9.
8. El-Gabalawy H, Guenther LC, Bernstein CN. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J Rheumatol Suppl 2010, 85:2-10. 10.3899/jrheum.091461, 20436161.
9. Lévy L, Fautrel B, Barnetche T. Schaeverbeke T. Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol 2008, 26:673-9.
10. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-7. 10.1161/01.CIR.0000054612.26458.B2, 12628952.
11. Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 2008, 121:S9-14. 2858687, 18926169.
12. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 2008, 121:S21-S31. 10.1016/j.amjmed.2008.06.014, 18926166.
13. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997, 145:408-15. 10.1093/oxfordjournals.aje.a009122, 9048514.
14. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, Linton MF, Raggi P, Stein CM. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003, 349:2407-15. 10.1056/NEJMoa035611, 14681506.
15. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003, 349:2399-406. 10.1056/NEJMoa035471, 14681505.
16. Vaudo G, Bocci EB, Shoenfeld Y, et al. Precocious intima-media thickening in patients with primary Sjogren's syndrome. Arthritis Rheum 2005, 52:3890-7. 10.1002/art.21475, 16320337.
17. van Leuven SI, Hezemans R, Levels JH, Snoek S, Stokkers PC, Hovingh GK, Kastelein JJ, Stroes ES, de Groot E, Hommes DW. Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. J Lipid Res 2007, 48:2640-6. 10.1194/jlr.M700176-JLR200, 17890779.
18. Vizzardi E, Raddino R, Teli M, Gorga E, Brambilla G. Dei Cas L. Psoriasis and cardiovascular diseases. Acta Cardiol. 2010, 65:337-40.
19. Krishnan E. Stroke subtypes among young patients with systematic lupus erythematosus. Am J Medicine 2005, 118:1415.
20. Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 2008, 59:1090-6. 10.1002/art.23935, 2778069, 18668583.
21. Zöller B, Li X, Sundquist J, Sundquist K. Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation 2011, 124:1012-20. 10.1161/CIRCULATIONAHA.110.965020, 21824919.
22. Rosen M, Hakulinen T. Use of disease registers. Handbook of epidemiology 2005, 231-52. Springer, Berlin, Ahrens W, Pigeot I.
23. The Swedish Hospital Discharge Register 1987-1996 quality and contents , The National Board of Health and Welfare, Stockholm, The Swedish Hospital Discharge Register 1987-1996.
24. Rothman KJ, Greenland S. Modern Epidemiology 1998, Lippincott-Raven, Philadelphia, 2.
25. O'Keefe JH, Carter MD, Lavie CJ. Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc 2009, 84:741-57. 10.4065/84.8.741, 2719528, 19648392.
26. Saidi S, Mahjoub T, Almawi WY. Lupus anticoagulants and antiphospholipid antibodies as risk factors for a first episode of ischemic stroke. J Thromb Haemost 2009, 7:1075-1080. 10.1111/j.1538-7836.2009.03446.x, 19422448.
27. Jilma B, Cvitko T, Winter-Fabry A, Petroczi K, Quehenberger P, Blann AD. High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Haemost 2005, 94:797-801.
28. Westlake SL, Colebatch AN, Baird J, et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 2010, 49:295-307. 10.1093/rheumatology/kep366, 19946022.
29. Westlake SL, Colebatch AN, Baird J, Edwards CJ, et al. Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 2011, 50:518-31. 10.1093/rheumatology/keq316, 21071477.
30. Roumie CL, Mitchel EF, Kaltenbach L, Arbogast PG, Gideon P, Griffin MR. Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke. Stroke 2008, 39:2037-45. 10.1161/STROKEAHA.107.508549, 18436878.
31. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998, 280:1930-5. 10.1001/jama.280.22.1930, 9851479.
32. National guidelines for stroke care 2009 Basis for control and management 2009, The National Board of Health and Welfare, Stockholm, In Swedish, National guidelines for stroke care 2009.
33. Validity of the diagnoses from the Swedish In-Care Register 1987 and 1995 National Board of Health and Welfare 2000, Stockholm, In Swedish, Validity of the diagnoses from the Swedish In-Care Register 1987 and 1995.
34. Lindblad U, Råstam L, Ranstam J, Peterson M. Validity of register data on acute myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med 1993, 21:3-9.
35. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. External review and validation of the Swedish national inpatient register. BMC Public Health 2011, 11:450. 10.1186/1471-2458-11-450, 3142234, 21658213.